Abstract
C alcium is an important element found in the body. calcium in the body binds to proteins, especially albumin and globulin. Calcium absorption in the intestine depends on vitamin D level. have hypocalcemia, due to hypoalbuminemia, loss of vitamin D-binding protein in the urine, and the use of steroid therapy. 3 Several studies have reported hypocalcemic states in children with NS. [4] [5] [6] [7] Low levels of calcium may lead to neuromuscular, cardiovascular, mental, and bone formation disorders.
Tetany is characteristic of neuromuscular disorders due to hypocalcemia. Symptoms may range from mild (perioral numbness, paresthesias, and muscle cramps) to severe (carpopedal spasm, laryngospasm, and focal or generalized seizures). The classic physical include Trousseau's and Chvostek's signs.
There have been limited studies on the effect of calcium and vitamin D supplementation on serum calcium levels and the clinical manifestations of hypocalcemia in NS patients. A study reports that NS patients who received calcium and vitamin D supplementation had significantly increased calcium ion levels and improved bone mineral density. 6 Another study in India shows a significant increase of serum calcium level, both in the group who were given calcium and vitamin D supplementation, and group who were not given the supplementation, in the first attack and infrequent relapse NS patients.
We aimed to evaluate the effect of calcium and vitamin D supplementation on serum calcium levels and clinical manifestations of hypocalcemia in idiopathic NS patients.
Methods
This randomized, single-blind, controlled trial of parallel design with repeated measurements was were patients with idiopathic NS active disease, defined as patients having their first attack, infrequent Table 1 . Age, gender, onset of illness, duration of illness, number of relapses, duration of steroid use, nutritional status, creatinine levels, serum calcium levels, serum calcium status, and type of nephrotic syndrome were similar between the two groups. Mean age at onset of illness months in the placebo group. Mean duration of steroid use in the treatment and placebo groups were 358.73 the study, the serum calcium levels increased in both (Table 2) .
Serum calcium levels were significantly higher no significant differences in serum calcium levels between the calcium and vitamin D supplementation group and the placebo group after 8 weeks (Factor-B; the patients had either sign (Table 3) . No side effects of calcium and vitamin D supplementation were Table 4 ).
Discussion
Calcium levels in nephrotic syndrome patients may decrease due to several mechanisms: hypoalbuminemia, decreased calcium absorption in the intestine due to loss of vitamin D-binding protein in the urine, and the use of steroid therapy. 3 Two studies reported that low albumin levels in NS patients were asssociated with low levels of ionized and serum calcium. 4, 7 frequent relapse and steroid-dependent NS. 6 We at the onset of the study (Table 1) . Similarly, other studies reported that hypocalcemia is found at a high incidence among NS patients. 4, 6, 7 There was a significant increase in serum calcium levels after 8 weeks in both groups. Therefore, we cannot conclude that calcium and vitamin D supplementation affected the alteration in serum calcium levels. disease (MCD) after an 8-week course of steroid therapy. Also, in patients with idiopathic NS who achieve remission with proteinuria resolution, serum calcium levels usually return to normal.
There were no significant differences in serum tion and placebo groups after 8 weeks of treatment.
The lack of difference in serum calcium levels between the two groups maybe because we only assessed serum calcium level at 8 weeks of study. At this end point, such, we should assess the serum calcium level at least twice during the study in order to further discern an effect of calcium and vitamin D supplementation. In idiopathic NS patients, serum calcium level is low, in accordance with the decrease in abumin level, but returns to normal after remission is achieved which usually occurs after 8 weeks. Steroid therapy can also affect serum calcium levels in NS patients. Steroids may inhibit calcium absorption by lowering duodenum. A study in NS patients showed that after the 4 th th weeks of steroid treatment, serum calcium levels were significantly lower than those at the initiation of therapy.
Hypocalcemia can lead to clinical manifestations related to neuromuscular, cardiovascular, and mental disorders, as well as disturbances in bone formation. Tetany is a common clinical manifestation associated with neuromuscular disorders. Trousseau's and Chvostek's signs are the physical findings A limitation of our study is the lack of dietary analysis to assess dietary intake of calcium and vitamin D. Also, the assessments on serum calcium levels and improvement of hypocalcemia clinical manifestations were performed only at 8 weeks of study, and should have been done at least twice to assess for an earlier effect of calcium and vitamin D supplementation.
In conclusion, normalization of serum calcium levels and improved clinical manifestations of hypocalcemia occur both in NS patients who receive calcium and vitamin D supplementation and those who do not. Good management of NS patients leads to improved serum calcium levels, with or without supplementation.
